Insights

These ASX 200 healthcare shares are holding up in today’s sea of red

With a resurgence of COVID-19 cases, the healthcare sector is home to some of the best performing ASX 200 shares on Monday.
The post These ASX 200 healthcare shares are holding up in today’s sea of red appeared first on The Motley Fool Australia. –

Almost every S&P/ASX 200 Index (ASX: XJO) sector opened in red on Monday.

Commodities are logging the heaviest losses, with the S&P/ASX Energy (INDEXASX: XEJ) and S&P/ASX Materials (INDEXASX: XMJ) down 2.12% and 2.36% respectively.

But amidst the sea of red, the S&P/ASX Health Care (INDEXASX: XHJ) is standing tall, up 2.06%.

Encouragingly, the resilient healthcare index is experiencing broad buying across the board, from heavyweight CSL Ltd (ASX: CSL) to Ansell Ltd (ASX: ANN).

Top performing ASX 200 healthcare shares today

CSL

The CSL share price has emerged as one of the best performing ASX 200 healthcare shares on Monday, lifting 2.49% to $284.63.

Unfortunately, CSL shares have struggled in the past month, losing 9% before today’s rally.

Adding further insult to injury could be this broker downgrade, with Credit Suisse flagging potential margin weakness due to challenging plasma collection conditions.

Sonic Healthcare Ltd (ASX: SHL)

The Sonic Healthcare share price is another ASX 200 healthcare winner on Monday.

Shares in the medical diagnostic services company are rallying towards record territory, currently 1.37% higher to $39.62.

Sonic Healthcare has played an active role in the nation’s COVID-19 testing, performing more than 18 million tests across 60 Sonic laboratories globally, according to its half-year results.

Resmed CDI (ASX: RMD)

The Resmed share price has gone from strength to strength after a stellar performance in June.

Resmed surged in mid-June following news that a competitor had to issue a major product recall for a number of its ventilator devices.

Resmed shares have added another 2.36% on Monday to $34.49, possibly looking at another record close.

The company announced the release of its fourth quarter results will be on Thursday, 5 August.

Fisher & Paykel Healthcare Corp Ltd (ASX: FPH)

Fisher & Paykel is another player in the respiratory device space that’s pushing higher today.

At the time of writing, Fisher & Paykel shares are up 1.57% to $29.17.

Despite a small win today, Fisher & Paykel shares have struggled to find headway in 2021, down 5.53% year-to-date.

Alongside its underperformance, a broker note out of UBS flagged the company’s earnings could be under pressure as a result of reduced COVID-19 hospitalisation rates.

The post These ASX 200 healthcare shares are holding up in today’s sea of red appeared first on The Motley Fool Australia.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of May 24th 2021

More reading

Why is the Temple & Webster (ASX:TPW) share price up over 3% today?
Why CSL, Humm, IntelliHR, & Vulcan shares are pushing higher

Why the Sonic Healthcare (ASX:SHL) share price hit an all-time high today
Brokers using the lockdown to upgrade earnings forecasts on these ASX 200 shares

The CSL (ASX:CSL) share price is down 9% in a month, here’s why

Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has recommended ResMed Inc. and Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!